BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Nov 01, 2010
 |  BC Week In Review  |  Company News  |  Other News

Amphastar Pharmaceuticals generics news

Amphastar filed a complaint in the U.S. District Court for the District of Columbia seeking to require FDA to release two detained U.S. shipments of semi-purified heparin imported from the company's subsidiary in China. Amphastar claimed that without the raw heparin, the company cannot begin the procedure to qualify...

Read the full 225 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >